Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Patients will be treated for 2 consecutive chemo cycles with the study drug for one and placebo for the other. In addition, patients will receive an injection before the chemo, either ondansetron (if receiving placebo inhalation) or normal saline) if receiving active study drug. They will take study medication for 3 days, 4 times daily and fill out VAS scores before and after doses. Patients will be given rescue medication with each dose.
Epistemonikos ID: e8ed38f71fbec2eede9b4e6f9f8d340b91922367
First added on: Apr 23, 2019